Association of advanced glycation end products with sarcopenia and frailty in chronic kidney diseaseJunko Yabuuchi, Yusuke Suzuki|Scientific Reports|2020Cited by 64
Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosisMingfeng Lee, Yusuke Suzuki|Clinical Kidney Journal|2023Cited by 55
The sodium–glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic miceZi Li, Yusuke Suzuki|FEBS Open Bio|2020Cited by 13
The role of oxidative stress markers in Indonesian Chronic Kidney Disease (CKD) patientsYusuke Suzuki, Budi Susetyo Pikir, Hendri Susilo et al.|Harvard Dataverse|2021Cited by 3